Skin and Soft Tissue Infection Prevalence in the US
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the prevalence of skin and soft tissue infections in the United States.
Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the prevalence of skin and soft tissue infections (SSTIs) in the United States.
Interview Transcript (slightly modified for readability)
“If you look at the overall data for all patients, it’s about 500 SSTIs per 10,000 patient-years, which is a little more than 5% of the overall population per year getting an SSTI. However, about 2 million of those cases (which is about half of those) end up going to the emergency department each year, suggesting that the cure is being differentiated between primary care clinics as well as emergency departments [which] can subsequently lead to admission to the hospital.”
